1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trial
In our study, treatment with risk-adapted, MR-guided SABR resulted in a high one-year local control and survival rate and could keep half of the patients off systemic therapy within the first year of follow-up.
Authors
- Kasper Madsen (ORCID: https://orcid.org/0009-0006-7612-3906)
- Tine Schytte (ORCID: https://orcid.org/0000-0002-6705-1561)
- Joshua Kim (ORCID: https://orcid.org/0000-0001-8371-2852)
- Gitte Fredberg Persson (ORCID: https://orcid.org/0000-0002-3363-3256)
- Susanne Lise Bekke (ORCID: https://orcid.org/0000-0001-5384-5988)
- Poul Geertsen (ORCID: https://orcid.org/0009-0007-8369-6806)
- Jakob Fink Topsøe
- Eva Serup‐Hansen (ORCID: https://orcid.org/0000-0001-6851-2086)
- Ivan R. Vogelius (ORCID: https://orcid.org/0000-0002-8877-1218)
- Pia Krause Møller (ORCID: https://orcid.org/0000-0002-0761-8028)
- Uffe Bernchou (ORCID: https://orcid.org/0000-0002-5309-2696)
- C.F. Behrens (ORCID: https://orcid.org/0000-0002-0686-1421)
- Anne Kiil Berthelsen
- Mette van Overeem Felter (ORCID: https://orcid.org/0000-0002-1069-5999)
- Mirjana Josipović (ORCID: https://orcid.org/0000-0001-8288-162X)
- Mette Pøhl
- Parag J. Parikh
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Herlev Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Henry Ford Hospital (US)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.radonc.2025.110748
- Citations
- 1
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- Varian Medical Systems
- National Research Centre
- Kræftens Bekæmpelse
- Odense Universitetshospital
- Villadsen Family Foundation